| Report ID | Date of report | Patient age | Patient gender |
| 135033 | Jun, 8, 2006 | Not specified | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Omniscan | gadodiamide |
Optimark | gadoversetamide |
| Name |
Aortic Embolus |
Nephrogenic Fibrosing Dermopathy |
Peripheral Ischaemia |
Skin Discolouration |
Results from eHealthMe : 211 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Aortic Embolus | 2 (0.95%) |
Nephrogenic Fibrosing Dermopathy | 16 (7.58%) |
Peripheral Ischaemia | 2 (0.95%) |
Skin Discolouration | 1 (0.47%) |
Top 3 (total: 44. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Magnevist | 145 (4.53%) |
Multihance | 131 (4.10%) |
Prohance | 65 (2.03%) |
Death reported: 8 (3.79% of total reports)
| Name | Count (% of total reports) |
Nephrogenic Systemic Fibrosis | 186 (88.15%) |
Injury | 70 (33.18%) |
Pain | 65 (30.81%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
